GHIT Fund Marks Japanese Government Interest In Exporting Tech for Global Health
This article was originally published in PharmAsia News
Executive Summary
Astellas, Daiichi Sankyo, Eisai, Shionogi and Takeda join first-of-its kind, government-backed venture to mine compound libraries and kick-start development of neglected disease therapies.
You may also be interested in...
FCPA In The China Framework Warrants Special Attention
The US Department of Justice, SEC and the Chinese government have all increased investigations of corrupt practices, and incriminating evidence is easier than ever to find. What can companies do to protect themselves?
Astellas Regains Japan Losses With Xtandi Expansion
Astellas’ geographic and indication expansion strategy for Xtandi matches patent losses in Japan.
Astellas Regains Japan Losses With Xtandi Expansion
Astellas’ geographic and indication expansion strategy for Xtandi matches patent losses in Japan.